The European Medicines Agency (EMA) has officially launched the European Shortages Monitoring Platform (ESMP), which became fully operational on January 29, 2025. This new system aims to enhance the monitoring and management of medicine shortages across the European Union (EU) and European Economic Area (EEA).

‍

The ESMP allows marketing authorisation holders (MAHs) and national competent authorities (NCAs) to report real-time data on the supply and demand of both nationally and centrally authorised medicines. This will help EMA and national regulators take proactive measures to prevent and mitigate shortages, particularly during public health crises or supply chain disruptions.

‍

From February 2, 2025, all MAHs and NCAs are required to use the ESMP for reporting shortages and availability issues. The platform is a key part of EMA’s expanded mandate and supports the work of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG).

‍

One of the major benefits of ESMP is its ability to centralize information, ensuring timely, accurate and transparent reporting. Additionally, the system provides public access to essential data through EMA’s shortages catalogue and national shortages portals, increasing awareness of supply risks.

‍

Medicine shortage surveillance is a proactive approach used by regulatory agencies and healthcare institutions to monitor and address potential disruptions in the supply of critical medicines. This surveillance involves systematic tracking of supply chains, real-time data analysis and collaboration with manufacturers to identify early warning signs of shortages. By assessing stock levels, distribution bottlenecks, and demand fluctuations, one can implement timely interventions, such as reallocating supplies or expediting alternative sourcing. This strategy enhances preparedness, reduces the impact of shortages on patients, and ensures a more resilient pharmaceutical supply system.

‍

The launch of the ESMP marks a significant step in strengthening Europe’s resilience against medicine shortages. By improving coordination and transparency, the platform enhances preparedness and response capabilities, safeguarding public health across the region.